(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

BIONIC-I

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: Estados Unidos

Snapshot rápido

BIONIC-I

ST13

US500000088985470

Classe

5, 9, 10, 35, 38, 41, 42, 44

Pedido

88985470

Registro

7854397

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

81

Atualização mais recente

08/07/2025

Tipo de marca

Verbal

Classes Nice

5, 9, 10, 35, 38, 41, 42, 44

Data de depósito

17/04/2020

Data de registro

08/07/2025

Data de expiração

-

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

08/07/2025

Última transação

08/07/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Fundamento do pedido

Foreign priority

Código do desenho

4

Tipo de titular

01

Localização do titular

Willowdale, ON, CA

Examinador

GAGLIARDI, JEANINE

Unidade examinadora

N20

Localização atual

FILE REPOSITORY (FRANCONIA)

Titulares e representantes

Titulares

Ma, Joseph J.K.

Representantes

James R Menker HOLLEY & MENKER, PA

Classificação técnica

Classes Nice

Classe 5Classe 9Classe 10Classe 35Classe 38Classe 41Classe 42Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Capsules sold empty for pharmaceuticals; diagnostic reagents for medical diagnostic use; neurologic medications for treating brain injuryspinal cord injuryseizure disordersmetabolic medications for treating diabetesgoutarthritisanemiapsychoactive medications; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of dissolvable films that facilitate the delivery of pharmaceutical preparations; pharmaceutical preparations for the treatment of neurological diseasesAlzheimer'sHuntington's Diseasecerebral palsy; pharmaceutical preparations for the treatment of neurological disordersbrain injuryspinal cord injuryseizure disorders; pharmaceutical preparations for the treatment of the diseasesdisorders and infections of the central nervous systembrainmovementspinal cord diseases; pharmaceutical preparations for the treatment of metabolic diseases and disordersdiabeteshypoglycemiagoutosteoarthritismuscular dystrophy and anemia; anti-inflammatory and antipyretic preparations; antibiotics; anticonvulsants; antidepressants; antidiabetic pharmaceuticals; antidiabetic preparations; antifungal medications; antihistamines; antiparasitics; antipyretics in the nature of antipyretic analgesics; antitumor drugspharmaceutical preparations for treating tumors; antivirals; bactericides; beta blockers; biocides; chemotherapeutics; diagnostic biomarker reagents for medical purposes; diagnostic preparations for medical purposes for detecting genetic predispositions; dietetic substances consisting of vitaminsmineralsamino acids and trace elementsdietetic infusions for medical use being intravenous fluids used for nutrition; diuretics; drug delivery agents in the form of coatings for tablets that facilitate the delivery of pharmaceutical preparations; drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; electrolytes for medical use; empty capsules for pharmaceutical purposes; fungal medications; hydrocortisone; analgesics; insulin; insulin injectors sold filled with insulin; intravenous fluids used for rehydrationnutrition and the delivery of pharmaceutical preparations; medical diagnostic reagents and assays for testing of body fluids; mixed antibiotic preparations; pharmaceutical hormonal preparationscorticosteroidshormone replacement therapy preparationsoral contraceptivesthyroid hormone preparations; pharmaceutical preparations and agents for the treatment and prevention of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of brain diseases and disordersepilepsyAlzheimer'scerebral palsyParkinson's diseasemultiple sclerosis; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of degenerative nerve diseases and disordersAlzheimer's diseaseParkinson's diseaseHuntington's disease and multiple sclerosis; pharmaceutical preparations for the treatment of glaucoma; pharmaceutical preparations for the treatment of immunologic diseasesautoimmune diseasesimmunologic deficiency syndromes; pharmaceutical preparations for the treatment of infectious diseasesrespiratory infections; pharmaceutical preparations for the treatment of metabolic disordersdiabetesbulimia nervosaanorexiaobesity and hypothyroidism; pharmaceutical preparations for the treatment of migraine; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations for the treatment of neuromuscular diseases and disorderscerebrovascular accident (stroke)Parkinson's diseasemultiple sclerosismyasthenia gravisHuntington's disease; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of viral diseasesherpeshepatitisAcquired Immune Deficiency Syndrome (AIDS); pharmaceutical preparations for treating hypoglycemia; pharmaceutical preparations for treating malignant tumors; steroids; surgical anesthetics; medical adhesives for binding woundssurgical adhesives; tumor suppressing agents

Classe 9

Acceleration sensors; analogue to digital converters; downloadable facial recognition software; downloadable facial analysis software; protective face shields for protective helmets; fashion eyeglasses; fashion spectacles; flight simulators; protective helmets for boxing; protective helmets for sports; safety helmets; sandglasses; ski goggles; ski helmets; smart watches; spectacle frames; spectacle holders; sports helmets; touch screens; vehicle drive training simulators; workmen's protective face-shields; smartwatches in the nature of wristwatches featuring a cellphone and display screen for viewingsending and recording text messages and emails; Dosage dispensers in the nature of machines for dispensing pre-determined dosages of medication

Classe 10

Apparatus used in implementing diagnosis tests designed to detect neurologic diseasemetabolic diseasecardiovascular diseaseinflammatory disease; medical apparatus for facilitating the administration of pharmaceutical preparations; blood glucose meters; blood glucose monitors for medical purposes; diabetes monitoring equipment for sampling and analyzing blood and body tissue in the nature of medical test kits for diabetes monitoring for home use; devices for measuring blood sugar; devices for measuring intracranial pressure; electrodes for medical purposes; electronic muscle stimulators for medical purposes; electronic nerve stimulators for medical purposes; forceps for medical use; heart rate monitors; heartbeat measuring apparatus; high frequency electromagnetic therapy apparatus; injection instruments without needles; lasers for surgical and medical use; magnetic resonance imaging apparatus for medical purposes; medical electrode; medical guidewires and parts and fittings therefor; medical image processors; medical ultrasound apparatus; ophthalmometers; ophthalmoscopes; optometric instrumentsinstruments for measuring the diameter of ophthalmic lenses; surgical forceps; surgical mesh comprised primarily of artificial materials; syringes for medical purposes; thermometers for medical purposes

Classe 35

Advertising and business management consultancy; advertising by transmission of on-line publicity for third parties through electronic communications networks; advertising relating to pharmaceutical products and in-vivo imaging products of others; advertising the goods and services of others; advertising the goods and services of others via electronic media and specifically the internet; business management advice; compilation of statistics; computerized market research services; cost analysis; management and compilation of computerized databases; market research services; providing business marketing information for others; advertising on the Internet for others; business management; business management consultancy; business strategy planning; database management; promoting the goods and services of others through advertisements on Internet websites; advertising services in the nature of providing marketing strategies for others; retail pharmacy services

Classe 38

Telecommunication servicespersonal communication services (PCS); telecommunications serviceselectronic exchange of data in the nature of voiceaudiovideotext and graphics stored in databases accessible via the Internetcomputer networks and wireless communications networks; instant messaging services; mobile phone communication services; voice over internet protocol (VOIP) services; web messaging services; audio teleconferencing; video teleconferencing; video broadcasting services over the internet or other communication networkselectronically transmitted videoaudioaudio visual content in the nature of television programsmoviesmusic video and user uploaded video clips; providing access to computer databases in the fields of social networking; telephone voice and text messaging services over computer and global communication networks; call diversion services in the nature of call forwarding services; telephone servicescell phone services; cellular telephone communication; cellular text messaging services; communication by means of mobile phones; e-mail services in the nature of electronic transmission of e-mail; e-mail transmission serviceselectronic transmission of e-mail; electronic mail services in the nature of electronic transmission of electronic mail; email services in the nature of electronic transmission of email; telephone servicesmobile phone services; paging by radio; providing access to the Internet; providing electronic mail serviceselectronic transmission of electronic mail; providing voice chat services; secure electronic mail services in the nature of secure electronic transmission of electronic mail; video conferencing services; teleconferencing and video conferencing services; voice mail services; wireless digital messaging services

Classe 41

Augmented reality video production; entertainment services in the nature of non-downloadable continuing television shows and movies in the fields of varietynewscomedy transmitted via the internet; entertainment services in the nature of providing non-downloadable videos and images featuring television shows and movies transmitted via wireless computer networks; health clubs for physical exercise; instruction in martial arts; language instruction; language interpretation; language interpreter services; language training services; law enforcement training services; meditation training; motion picture and video rental services; museum services; music composition; music composition services; music transcription; night club services; nursery school services; officiating at sports competition; online casino gaming servicesproviding on-line casino games; online gambling services; photographic computer imaging; physical education; physical education services; physical fitness instruction; piano instruction; planetarium services; practical training in the field of welding; providing entertainment information in the field of television programming; providing information in the field of exercise via an interactive website; providing newseditorialsopinions concerning current events via a website; sign language interpretation; translation; tutoring in the fields of science and medicine; wagering services

Classe 42

Providing temporary use of non-downloadable facial recognition software; providing temporary use of non-downloadable facial analysis software; colour analysis in the nature of laboratory services; medical laboratory services in the nature of analysis services for diagnostic and treatment purposes

Classe 44

Preparation and dispensing of medications; providing information relating to the preparation and dispensing of medications; providing information to patients in the field of administering medications; medical services in the nature of medical and surgical diagnostic services; medical imaging; medical screening; pharmacy dispensary servicespreparation of prescriptions in pharmacies; pharmaceutical advice; pharmaceutical consultancy services; medical services in the nature of conducting of medical examinations; addiction treatment services; cosmetic and colour analysis for cosmetic purposes; healthcare in the nature of eyecare services; health and beauty care services provided by saunasbeauty salonssanatoriumshairdressing salons and massage parlors; health care services provided by a health spa; medical services in the nature of light therapy services; medical house call services; medical testing services; mental health screening services; psychological diagnosis services; health counsellingmeditation counselling

Publicações

Histórico de despachos e eventos da marca no USPTO.

81 publicações encontradas

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

08/07/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

08/07/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

20/05/2025

PUBO

PUBLISHED FOR OPPOSITION

20/05/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

14/05/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

22/04/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

12/04/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

12/04/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

12/04/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

12/04/2025

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

12/04/2025

XAEC

EXAMINER'S AMENDMENT ENTERED

12/04/2025

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

12/04/2025

GNEA

EXAMINERS AMENDMENT E-MAILED

12/04/2025

CNEA

EXAMINERS AMENDMENT -WRITTEN

12/04/2025

DPCC

DIVISIONAL PROCESSING COMPLETE

10/04/2025

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

27/02/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

18/02/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

18/02/2025

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

18/02/2025

XELG

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

09/11/2024

XELR

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

09/11/2024

DRRR

DIVISIONAL REQUEST RECEIVED

21/08/2024

ERTD

TEAS REQUEST TO DIVIDE RECEIVED

21/08/2024

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

17/08/2024

GNFR

FINAL REFUSAL E-MAILED

17/08/2024

CNFR

FINAL REFUSAL WRITTEN

17/08/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/08/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/08/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/08/2024

XELG

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

05/05/2024

XELR

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

05/05/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

05/02/2024

GNRT

NON-FINAL ACTION E-MAILED

05/02/2024

CNRT

NON-FINAL ACTION WRITTEN

05/02/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

22/01/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

22/01/2024

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

18/01/2024

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

05/12/2023

GNSL

LETTER OF SUSPENSION E-MAILED

05/12/2023

CNSL

SUSPENSION LETTER WRITTEN

05/12/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

20/11/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

20/11/2023

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

18/11/2023

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

23/08/2023

GNSI

INQUIRY TO SUSPENSION E-MAILED

23/08/2023

CNSI

SUSPENSION INQUIRY WRITTEN

23/08/2023

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

05/08/2023

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

23/01/2023

GNSL

LETTER OF SUSPENSION E-MAILED

23/01/2023

CNSL

SUSPENSION LETTER WRITTEN

23/01/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/01/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/01/2023

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

06/01/2023

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

15/07/2022

GNSI

INQUIRY TO SUSPENSION E-MAILED

15/07/2022

CNSI

SUSPENSION INQUIRY WRITTEN

15/07/2022

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

22/06/2022

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

01/12/2021

GNSL

LETTER OF SUSPENSION E-MAILED

01/12/2021

CNSL

SUSPENSION LETTER WRITTEN

01/12/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/11/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/11/2021

ALIE

ASSIGNED TO LIE

09/11/2021

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

04/11/2021

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

04/08/2021

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

27/10/2020

GNSL

LETTER OF SUSPENSION E-MAILED

27/10/2020

CNSL

SUSPENSION LETTER WRITTEN

27/10/2020

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

16/10/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

16/10/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

16/10/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/10/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/10/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/10/2020

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

10/07/2020

GNRT

NON-FINAL ACTION E-MAILED

10/07/2020

CNRT

NON-FINAL ACTION WRITTEN

10/07/2020

DOCK

ASSIGNED TO EXAMINER

09/07/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

27/04/2020

NWAP

NEW APPLICATION ENTERED

21/04/2020

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace BIONIC-I ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.